For example, elevated proportions of CD4+CD25highFOXP3+ Treg in PBMC of cancer patients have been reported, and accumulations of Treg in the tumor microenvironment are associated with reduced patient survival [1]–[4]. The gene discussed is CD4; the disease is cancer.